Nicklas is 300 kilometres away. He waves and hands you a piece of chalk. You take it from him and draw on the board.
Concrete can tolerate much more force that previously believed, which could open the door to a new kind of road structure: a floating tunnel.
How do we protect astronauts in space from breathing dangerous gases? A German-Norwegian hi-tech optical gas sensor provides a solution.
Norwegian researchers are investigating how a snake robot might carry out maintenance work on the International Space Station (ISS), study comets, and explore the possibility of living and working in lava tunnels on the Moon.
Heavy-duty trucks will soon be driving around in Trondheim, Norway, fuelled by hydrogen created with solar power, and emitting only pure water vapour as “exhaust”. Not only will hydrogen technology revolutionize road transport, it will also enable ships and trains to run emission-free.
State-of-the-art solar cells are efficient – but are even more so when they are kept clean. A cleaning robot developed by Norwegian researchers enables solar panels to deliver at full capacity.
Facebook is an important source of not only genuine, but also fake news. But now a new tool has been developed to expose the fakers.
Nils Røkke, Director of Sustainability at SINTEF, is the new Chairman of the European Energy Research Alliance.
Researchers from Norway and Singapore are working together to build cities floating at sea and underground universities.
How can ships travelling in the Arctic maintain their position when ice pushes them in different directions?
Researchers rely on super microscopes to develop more efficient next-generation batteries.
Researchers at NTNU are developing a robot that will be controlled by living brain cells.
Syrian refugee children often do not learn to read in their native Arabic. But two new games are set to change that.
Recording and storing millions of fingerprints is a high-risk operation. Scientists are constantly searching for new and better security solutions to protect your information.
This July, Team Sky rider Chris Froome will try for his fourth victory in the Tour de France. The aerodynamic clothing he’ll likely wear during time trials is being developed at NTNU.
Allergies to antibiotics are the commonest form of medication allergies and, in the worst cases, can result in anaphylaxis and death. SINTEF is participating in the development of a new allergy test that will make it easier to provide patients with safe and correct treatments.
The fluid, which resembles brain tissue, makes ultrasound images easier to interpret during an operation. This will make it easier for surgeons to remove brain tumours more accurately.
As the world struggles to make progress to limit climate change, researchers are finding ways to adapt to warmer winter temperatures — by developing environmentally friendly ways of producing artificial snow.
Visualizing oil reservoirs or tectonic plates under the seafloor requires lots of computing power and the imagination to envision what the data are showing you. That’s Martin Landrø’s work world. But he’s also fascinated by how teachers from a century ago taught their students about the Earth and the way it moves around the sun.
An enzyme found in many bacteria, including the bacterium that gives us strep throat, has given mankind a cheap and effective tool with which to edit our own genes. This technology, called CRISPR, is also being used to understand how the immune system responds to a viral attack.
In a few years we’ll be able to charge virtually wherever and whenever we want with only minimal buildout of the power grid, according to electrical engineering professor Magnus Korpås.
Japan is at the forefront of building all kinds of different robots, from industrial machines to robots that look like humans and can talk to us. The only purpose for these humanoid robots is to make us happy.
A team of Norwegian, French and Australian researchers is the first in the world to succeed in quantifying the effects of radiation on individual cancer cells. This means that radiation therapies can now be tailored to individual tumours and thus be more effective.